Product Name | MF | CAS | Details |
---|
Diphosgene | C2Cl4O2 | 503-38-8 | Details |
4-(Pyridin-2-ylmethyl)phenol | C12H11NO | 58498-11-6 | Details |
4-(Piperidin-4-yl)-4,5-dihydro-1H-1,2,4-triazol-5-one hydrochloride | C7H13ClN4O | 1795464-24-2 | Details |
N-Butyl-4-chloro-2-hydroxybenzamide | C11H14ClNO2 | 575-74-6 | Details |
Ethyl 1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine-2-carboxylate | C16H14N2O4S | 146603-30-7 | Details |
C18orf8 antibody | Details |
Methyl 1-ethoxycyclobutane-1-carboxylate | C8H14O3 | 2031269-38-0 | Details |
Methyl 2-methylthiopropionate | C5H10O2S | 61366-76-5 | Details |
DL-4-Hydroxymandelic acid | C8H8O4 | 1198-84-1 | Details |
2-Amino-4-cyclopropylpyridine | C8H10N2 | 908269-97-6 | Details |
Acetyl-(D-Trp16)-Endothelin-1 (16-21) | C46H62N8O10 | 143037-33-6 | Details |
1-(4-Sulfamoylbenzenesulfonyl)piperidine-4-carboxylic acid | C12H16N2O6S2 | 872107-85-2 | Details |
1-(Phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid | C14H10N2O4S | 245064-80-6 | Details |
1-(1-Phenyl-1H-imidazol-2-yl)ethan-1-one | C11H10N2O | 66869-82-7 | Details |
Girentuximab | 916138-87-9 | Details |
1-[4-(Dimethylamino)-2-hydroxyphenyl]ethan-1-one | C10H13NO2 | 107070-69-9 | Details |
MS 023 dihydrochloride | C17H26ClN3O | 1992047-64-9 | Details |
5-Bromo-6-chloro-3-indolyl b-D-glucuronide | C14H13BrClNO7 | 144110-42-9 | Details |
Methyl 4,5,6,7-tetrahydro-1H-indazole-3-carboxylate | C9H12N2O2 | 32286-98-9 | Details |
1-[(1-Aminobutan-2-yl)oxy]-2-methylbenzene hydrochloride | C11H18ClNO | 1384428-01-6 | Details |
C19orf43 antibody | Details |
3-[(2-Aminophenyl)sulfanyl]-1-methylpyrrolidin-2-one | C11H14N2OS | 1344249-00-8 | Details |
N-[4-Amido-3-(trifluoromethyl)phenyl-3-[(4-fluorophenyl)sulphinyl]-2-hydroxy-2-methylpropanamide | C18H16F4N2O5S | 2200280-97-1 | Details |
3-(4-Fluorophenyl)oxolane-2,5-dione | C10H7FO3 | 630067-33-3 | Details |
Difucosyllacto-N-tetraose | Details |
(R)-Apomorphine hydrochloride hemihydrate | C17H20ClNO3 | 41372-20-7 | Details |
5-Bromo-2-fluoro-4-methylbenzoic acid | C8H6BrFO2 | 515135-65-6 | Details |
Plexin A2 antibody | Details |
1-(4-Aminophenyl)-2,2-dimethylpropan-1-one | C11H15NO | 892157-47-0 | Details |
(5-Bromo-1-methyl-1H-1,3-benzodiazol-2-yl)methanol | C9H9BrN2O | 887571-22-4 | Details |
Affinity Purified anti-Human Fibronectin Antibody | Details |
FAM134A antibody | Details |
5-Methoxypyridine-3-carbothioamide | C7H8N2OS | 342602-97-5 | Details |
1-(2-Methoxyethyl)piperidin-4-ol | C8H17NO2 | 512778-95-9 | Details |
BMP8B antibody | Details |
2-[5-(Oxolan-2-yl)-4H-1,2,4-triazol-3-yl]ethan-1-amine dihydrochloride | C8H14N4O.2ClH | 2287287-36-7 | Details |
Sequestosome 1 antibody | Details |
2-{[(tert-Butoxy)carbonyl]amino}-2-(1,5-dimethyl-1H-pyrazol-4-yl)acetic acid | C12H19N3O4 | 1536009-93-4 | Details |
2-(4-Butylphenyl)propionic acid, racemic | C13H18O2 | 3585-49-7 | Details |
SURF6 Blocking Peptide | Details |
N-Cyclopropyl-N-[(4-methoxyphenyl)methyl]-1-benzofuran-2-carboxamide | C20H19NO3 | 930082-11-4 | Details |
Cyclo(Tyr-Leu) | C15H20N2O3 | 82863-65-8 | Details |
[5-Methyl-2-(propan-2-yl)cyclohexyl]methanamine hydrochloride | C11H23N·HCl | 1212151-30-8 | Details |
Adenosine 5'-monophosphate sodium salt [1',2',3',4',5'-13C5] | C10H12N5Na2O7P | Details |
Methyl (methyl 3-deoxy-D-arabino-hept-2-ulopyranosid)onate | C9H16O7 | 85549-51-5 | Details |
Cleomiscosin B | C20H18O8 | 76985-93-8 | Details |
3-[(4-Aminopiperidin-1-yl)methyl]benzonitrile | C13H17N3 | 725212-23-7 | Details |
Matsukaze-lactone | C20H14O6 | 3153-73-9 | Details |
Methyl 3,5-di-O-acetyl-2-deoxy-2-(trifluoromethyl)-a-D-ribofuranoside | C11H15F3O6 | 159945-01-4 | Details |
Phosphotungstic acid hydrate | H3O41PW12(-2) | 12501-23-4 | Details |
1-{[4-(4-Fluorophenyl)piperazin-1-yl]methyl}cyclopropan-1-amine | C14H20FN3 | 1487905-36-1 | Details |
CPSF2 Blocking Peptide | Details |
ZNF763 antibody | Details |
L-Thymidine | C10H14N2O5 | 3424-98-4 | Details |
SRGAP1 antibody | Details |
4-(3-Bromophenyl)butan-1-ol | C10H13BrO | 218153-01-6 | Details |
3-(Dimethylphosphoryl)benzoic acid | C9H11O3P | 53888-92-9 | Details |
3-Phenyl-1,2,4-oxadiazol-5-ol | C8H6N2O2 | 1456-22-0 | Details |
5,6-Dibromoacenaphthene | C12H8Br2 | 19190-91-1 | Details |
Verrucarol | C15H22O4 | 2198-92-7 | Details |
1-(4-Bromo-1H-pyrrol-2-yl)-2,2,2-trichloroethanone | C6H3BrCl3NO | 72652-32-5 | Details |
Creatine Kinase protein (Porcine) | Details |
STRAD antibody | Details |
GPR161 antibody | Details |
Vulgarin | C15H20O4 | 3162-56-9 | Details |
2-(3-{[(tert-Butoxy)carbonyl]amino}-2-chlorophenyl)acetic acid | C13H16ClNO4 | 672309-92-1 | Details |
1-(3,4-Diethoxybenzoyl)piperidine-3-carboxylic acid | C17H23NO5 | 926267-25-6 | Details |
Goat anti Mouse Lambda Light Chain (HRP) | Details |
2',3',5'-Tri-O-acetyl-5-bromouridine | C15H17BrN2O9 | 105659-32-3 | Details |
GGT1 antibody | Details |
Ethinylestradiol-HRP | Details |
DNA antibody | Details |
2-Chloro-4-(piperazin-1-yl)-1,3,5-triazine dihydrochloride | 2230807-23-3 | Details |
Prostaglandin D2 Receptor antibody | Details |
4-Cyclopropyl-1H-indole-2-carboxylic acid | C12H11NO2 | 1514445-81-8 | Details |
Anti Chromogranin A (343-360) (Rat) Serum | Details |
ID3 antibody | Details |
3-Carbamoyl-2-(2-fluorobenzenesulfonamido)propanoic acid | C10H11FN2O5S | 1396962-91-6 | Details |
EPOr Blocking Peptide | Details |
2,3,4-Trimethylquinoline | C12H13N | 2437-72-1 | Details |
3-(2,2-Dimethyl-1,3-dioxolan-4-yl)propan-1-ol | C8H16O3 | 6318-30-5 | Details |
4-(Difluoromethyl)-2-(trifluoromethyl)benzoic acid | C9H5F5O2 | 2248272-02-6 | Details |
[2-(2-Thiazolylazo)-4-cresyl]-beta-D-glucuronide, sodium salt | Details |
Mac2BP ELISA kit | Details |
STX11 protein (His tag) | Details |
JNJ-67856633 | C20H11F6N5O2 | 2230273-76-2 | Details |
1-Benzyl-3-(pyrrolidin-2-yl)piperidine | C16H24N2 | 524674-29-1 | Details |
RP2 antibody | Details |
3-Amino-2-[(3-methoxyphenyl)methyl]propanoic acid hydrochloride | C11H16ClNO3 | 1864063-05-7 | Details |
4-Amino-5-[(4-methoxyphenoxy)methyl]-4H-1,2,4-triazole-3-thiol | C10H12N4O2S | 723332-65-8 | Details |
BPN14770 | C21H15ClF3NO2 | 1606974-33-7 | Details |
benzo[3,4-d]1,3-dioxolen-5-yl(3-pyridylmethyl)(2-thienylsulfonyl)amine | C17H14N2O4S2 | 920621-61-0 | Details |
3-Cyano-5-(trifluoromethyl)benzoic Acid | C9H4F3NO2 | 942077-16-9 | Details |
Ethyl[(3-methylphenyl)methyl]amine | C10H15N | 209051-77-4 | Details |
5-Bromo-2-(methylsulfanyl)-1,3-thiazole | C4H4BrNS2 | 956293-02-0 | Details |
4-Methylumbelliferyl myo-inositol-1-phosphate, N-methyl-morpholine salt | C21H30NO12P | 244145-23-1 | Details |
6-O-a-D-Glucosyl-a-cyclodextrin | C42H70O35 | 10058-19-2 | Details |
5-Chloro-1,3-dioxaindane-4-carbaldehyde | C8H5ClO3 | 249636-63-3 | Details |
H-KLTWQELYQLKYKGI-OH | C92H143N21O23 | 917760-16-8 | Details |
Methyl 3-amino-5,6,7,8-tetrahydronaphthalene-2-carboxylate | C12H15NO2 | 858022-64-7 | Details |
Product Total: Product Page: | ||||
492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 |